September 21, 2011
OSLO, NorwayHosfeth Biocare (HBC), the Oslo, Norway-based division of Hofseth International AS, appointed Missoula, MT-based TSI Health Sciences as its exclusive distributor for key markets in the dietary supplement and human nutrition sector. The announcement was made by Sjur Jenssen, CEO of Hofseth Biocare, who added TSI will complement the HBC teams commitment to service and science-based support for brand owners marketing this unique range of omega-3 oil ingredients.
Hofseth Biocare holds global patent protection on its method for processing marine biomass in a low temperature, enzyme driven process. This approach yields ingredients like salmon oil that are fresh, pure and 100-percent sustainable, with no impact on wild salmon populations. Rapid processing time and unmatched capacity and traceability make the companys offerings a truly new and interesting option for softgel and liquid supplement marketers and manufacturers
TSI has been watching the omega-3 space for many years and this is the best ingredient opportunity we have seen to effectively deliver a point of difference to this category and marketplace," said Larry Kolb, president, TSI Health Sciences. We look forward to building awareness and sales of Hofseths proprietary salmon oil ingredients through our global marketing offices."
You May Also Like
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023